Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Sentimental tree to shine at Arctic League annual broadcast - 2Iranian-linked drone attack kills Kurdish couple in northern Iraq
- 3Grasping Wrongdoings and Crimes: A Correlation
- 4False fuel prices in fabricated graphics circulate in Malaysia as Iran war continues
- 5Whale stranded off Germany for days found stuck again
- The Best Music Collections of the 10 years
- Instructions to Distinguish the Wellbeing Dangers Related with 5G Pinnacles
- ‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- The Best Games On the planet
- Australian State Triggers Emergency Powers Amid Fuel Crisis
- Spain breaks jobs record with 22 million Social Security contributors
- ‘I love this work, but it’s killing me’: The unique toll of being a spiritual leader today
- Lego's $650 Pokémon set is already sold out as demand, preorders surge
- Iran begins cloud seeding to induce rain amid historic drought
